Focus on the clinical ramifications of antipsychotic choice for the risk for developing type 2 diabetes mellitus.
Citrome
Leslie
L
New York University School of Medicine, NY, USA. citrome@nki.rfmh.org
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D012306:Risk; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents